![Lei Yang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lei Yang
Presidente presso Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
Posizioni attive di Lei Yang
Società | Posizione | Inizio | Fine |
---|---|---|---|
Hubei Grand Life Science & Technology Co., Ltd
![]() Hubei Grand Life Science & Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Hubei Grand Life Science & Technology Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its main products include taurine, taurine powder, theanine, thearine powder, and L-carnitine series. The company was founded in 1958 and is headquartered in Huangshi, China. | Direttore/Membro del Consiglio | - | - |
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
![]() Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Presidente | - | - |
Storia della carriera di Lei Yang
Statistiche
Distribuzione geografica
Cina | 3 |
Posizioni
Director/Board Member | 1 |
Chairman | 1 |
Settori
Health Technology | 2 |
Process Industries | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Hubei Grand Life Science & Technology Co., Ltd
![]() Hubei Grand Life Science & Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Hubei Grand Life Science & Technology Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its main products include taurine, taurine powder, theanine, thearine powder, and L-carnitine series. The company was founded in 1958 and is headquartered in Huangshi, China. | Health Technology |
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
![]() Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Process Industries |
- Borsa valori
- Insiders
- Lei Yang
- Esperienza